EUVIMEDEUVIMED entdecken
Crossref

Synthesis of Some New Xanthine Derivatives and Evaluation of DPP IV Inhibitory Activities

Erol Akgün iD, Leyla Yurttaş iD, Sevde Nur Biltekin Kaleli iD, Derya Osmaniye iD, Barkın Berk, Şeref Demirayak

Archiv der Pharmazie · 2026

DOI: 10.1002/ardp.70362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Erol Akgün und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Graduate Education, Pharmaceutical Chemistry, Anadolu University, Eskişehir, Turkey. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidase IV Inhibitors, Dipeptidyl Peptidase 4, Xanthines. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Anadolu University Scientific Research Project Coordination.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dipeptidyl peptidase IV (DPP IV) inhibition prolongs incretin activity and represents an established therapeutic strategy for the management of type 2 diabetes mellitus. To investigate the underexplored combination of benzyl groups at the N7 position and a piperazine‐linked arylthiazole moiety at the C8 position of the xanthine scaffold, 15 novel compounds ( 6a–6o ) were synthesised. The synthetic route involved bromination at the C8 position of theophylline, introduction of benzyl groups at the N7 position, replacement of the bromine atom at the C8 position with piperazine, and subsequent cyclocondensation with phenacyl thiocyanate derivatives. All final compounds were characterised by 1 H and 13 C NMR spectroscopy, high‐resolution accurate‐mass mass spectrometry, and analytical HPLC. All derivatives inhibited DPP IV in the low‐nanomolar range, with compounds 6c and 6b showing the highest activities, with IC 50 values of 3.95 ± 0.53 and 4.04 ± 0.65 nM, respectively. NIH3T3 cytotoxicity IC 50 values ranged from 28.52 to 397.63 µM, indicating substantial preliminary concentration margins relative to DPP IV inhibition. Molecular docking, 100 ns molecular dynamics simulations, interaction‐fingerprint analyses and trajectory‐based MM/PBSA calculations supported persistent interactions with key DPP IV active‐site residues. These results identify the synthesised derivatives, particularly 6b and 6c , as promising lead structures for further optimisation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dipeptidyl-Peptidase IV InhibitorsDipeptidyl Peptidase 4XanthinesAnimalsStructure-Activity RelationshipMolecular Docking SimulationMiceMolecular StructureNIH 3T3 CellsHumansDose-Response Relationship, DrugMolecular Dynamics Simulation

Stichwörter der Autor:innen

DPP IV inhibitionmolecular dockingmolecular dynamicsthiazolexanthine

Substanzen

Dipeptidyl-Peptidase IV InhibitorsDipeptidyl Peptidase 4Xanthines

Autor:innen und Institutionen

  • Institute of Graduate Education, Pharmaceutical Chemistry, Anadolu University, Eskişehir, Turkey.
  • Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Marmara University, Istanbul, Turkey.
  • Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskişehir, Turkey.
  • Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Istanbul Medipol University, Istanbul, Turkey.
  • Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul Okan University, Istanbul, Turkey.

ORCID-Profile: Erol Akgün, Leyla Yurttaş, Sevde Nur Biltekin Kaleli, Derya Osmaniye

Förderung

  • Anadolu University Scientific Research Project Coordination

Zitieren

APA

Akgün, E., Yurttaş, L., Kaleli, S. N. B., Osmaniye, D., Berk, B., & Demirayak, Ş. (2026). Synthesis of Some New Xanthine Derivatives and Evaluation of DPP IV Inhibitory Activities. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70362

Vancouver

Akgün E, Yurttaş L, Kaleli SNB, Osmaniye D, Berk B, Demirayak Ş. Synthesis of Some New Xanthine Derivatives and Evaluation of DPP IV Inhibitory Activities. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70362

BibTeX
@article{Akgn2026,
  author = {Akgün, Erol and Yurttaş, Leyla and Kaleli, Sevde Nur Biltekin and Osmaniye, Derya and Berk, Barkın and Demirayak, Şeref},
  title = {Synthesis of Some New Xanthine Derivatives and Evaluation of DPP IV Inhibitory Activities},
  journal = {Archiv der Pharmazie},
  year = {2026},
  doi = {10.1002/ardp.70362}
}
Kostenlos starten →